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Background
Psychotropic medications work on the brain to affect
mental function and behaviour. For over 20 years, con-
cern has been raised over the overuse of psychotropic
medication, particularly antipsychotics and benzodiaze-
pines (‘sedatives’) in nursing homes. The Reducing Use
of Sedatives (RedUSe) project was developed as a multi-
strategic, interdisciplinary initiative aimed to promote
the quality use of sedative medication in this setting.
The key strategies of RedUSe, namely audit & feedback,
education and medication review, were tested in a con-
trolled 6-month trial of 25 homes in 2008/2009. The
intervention significantly reduced the rates of antipsy-
chotic and benzodiazepine use and doubled the number
of sedative dosage reductions. In addition, the rate of
new sedative prescribing in intervention homes was
reduced to a quarter of the rate observed in control
homes. In 2013, the Australian Government awarded
substantial funding to expand RedUSe to 150 nursing
homes around the country. This abstract describes how
the RedUse project was evaluated and enhanced before
national expansion.
Materials and methods
A thorough assessment of the barriers and enablers
associated with the initial RedUSe trial was performed
in line with the Theoretical Domains Framework (TDF).
A qualitative methodology comprising of two focus
groups with nurses and pharmacists was selected to
ascertain this information. Behavioural change techni-
ques were subsequently identified to overcome the bar-
riers and enhance the enablers, and tested in a pilot roll
out phase comprising of 27 nursing homes across three
states. Feasible outcome measures were also designated.
Results
The main barriers to the RedUSe trial were the belief
that sedative medications improved resident quality of
life, perceived roles of health practitioners in reviewing
sedatives and poor GP engagement. The RedUSe project
was enhanced by the development of a customized
training program which challenged the belief that seda-
tive use enhances resident quality of life. The training
also clearly defined health practitioner roles in relation
to medication review processes. The training was deliv-
ered via two facilitated interactive small group work-
shops which combined one didactic lecture, a case study
and small group activities. An educational DVD was
also produced to show at all training sessions. Academic
detailing was delivered by trained detailers to inform
and engage GPs.
Conclusions
The TDF proved an effective tool to identify the key
barriers and enablers to the RedUSe project, facilitating
the incorporation of several novel behavioural change
techniques. The success of the expanded project will be
reported after full implementation and evaluation is
completed.
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